We are at a turning point in the fight against Alzheimer’s disease with the emergence of disease-modifying therapies for early symptomatic stages of the disease and availability of diagnostic tools providing patients with new hope.

Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The University of Cincinnati researchers and an Alzheimer's Association expert weigh in.

Alzheimer’s disease is primarily caused by the buildup of amyloid plaques and neurofibrillary tangles in the brain, which disrupt communication between neurons and ultimately lead to their death. Remember,

Researches have helped in detecting the disease in early stages and drugs are now being made available for an effective and durable disease management, writes Vanita Srivastava.